MARATHON CAPITAL MANAGEMENT - PDL BIOPHARMA INC ownership

Back to all holdings Add to watchlist

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 206 filers reported holding PDL BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
MARATHON CAPITAL MANAGEMENT ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q2 2016$79,000
-4.8%
25,0000.0%0.04%
-4.7%
Q1 2016$83,000
-5.7%
25,0000.0%0.04%
-8.5%
Q4 2015$88,000
-30.2%
25,0000.0%0.05%
-26.6%
Q3 2015$126,000–25,000–0.06%–
 Download
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2015
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders